BAP

Credicorp
D

BAP

Arincen67/100B

Credicorp P/E ratio

Credicorp's P/E ratio is 13.44: its share price of 361.14 over its earnings per share of 26.88 over the last twelve months.

Today
13.44
Forward P/E, next 12 months
10.92
PEG ratio
1.08
Median, 5 years
10.41
Low, 5 years
6.85
High, 5 years
16.54

P/E ratio = price ÷ EPS (last 12 months) = 361.14 ÷ 26.88 = 13.44

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Credicorp's P/E high compared with its own history?

Credicorp's P/E of 13.4 is near the top of its 5-year range (6.9 to 16.5, median 10.4). Analysts do not expect faster growth than in recent years, so it is expensive compared with its own history.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202710.73———
FY2026 · Estimate31 Dec 202612.29———
Today13.4410.9298.69B5.90B
FY202531 Dec 202511.127.8276.99B6.93B
FY202431 Dec 20249.787.8255.01B5.62B
FY202331 Dec 20239.097.6044.22B4.87B
FY202231 Dec 20228.628.4541.03B4.76B
FY202131 Dec 202110.5311.0138.67B3.67B
FY202031 Dec 2020135.8811.0147.14B346.89M
FY201931 Dec 201912.8911.0156.09B4.35B
FY201831 Dec 201814.6011.0159.44B4.07B
FY201731 Dec 201712.7811.0153.45B4.18B
FY201631 Dec 201611.6711.0142.12B3.61B
FY201531 Dec 20158.347.7226.37B3.16B
FY201431 Dec 201415.69—37.99B2.42B
FY201331 Dec 201318.95—29.51B1.56B
FY201231 Dec 201213.97—29.77B2.13B
FY201131 Dec 201112.31—23.44B1.90B
FY201031 Dec 201015.34—26.50B1.73B
FY200931 Dec 200912.10—17.72B1.46B
FY200831 Dec 200810.78—12.51B1.16B
FY200731 Dec 200716.30—18.20B1.12B
FY200631 Dec 200613.83—10.45B755.54M
FY200531 Dec 20059.32—6.25B670.92M
FY200431 Dec 20048.92—4.14B463.97M
FY200331 Dec 200311.72—3.70B315.33M
FY200231 Dec 200216.98—2.53B149.03M
FY200131 Dec 200112.87—2.41B187.59M
FY200031 Dec 200027.13—1.69B62.44M
FY199931 Dec 199926.03—3.97B152.58M
FY199831 Dec 199816.33—2.30B140.80M
FY199731 Dec 199712.30—3.60B293.00M

Figures in PEN. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Credicorp's P/E ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.